Michael Boyle (@mpboylemd) 's Twitter Profile
Michael Boyle

@mpboylemd

President and CEO, Cystic Fibrosis Foundation. Professor of Medicine, Johns Hopkins. Member of Team CF. Tweets are my own

ID: 884342196

calendar_today16-10-2012 12:33:00

47 Tweet

306 Takipçi

52 Takip Edilen

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

The CFF Science team will be concentrating this week on advancing opportunities with companies developing new technologies for restoring CFTR function. We will need these new approaches to assure we eventually restore CFTR function for each and every person with CF! #TeamCF

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

Did you know that at the Senate press conference last week on the importance of protecting insurance for individuals with preexisting conditions, 5 of 47 senators featured stories of people with CF? Amazing! Mary Dwight and the CFF advocacy team are getting it done! #TeamCF

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

Congratulations to Vertex for their submission today of the new drug application for the triple combination tezacaftor/elexacaftor/ivacaftor to the FDA. Grateful for the many members of the CF community that have participated in trials and made this application possible! #TeamCF

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

Infection Researchers! Spread the word that CF is the place to bring your best ideas: Awards for Infection Research Initiative cff.org/Research/Resea… via Cystic Fibrosis Foundation

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

The CFF Science Team is headed to Alabama this week to meet with the SRI/UAB team on their CFF-sponsored program to develop new therapies for those with Nonsense ("X") Mutations. A tough nut to crack, but over 750,000 compounds screened to date and many more on the way! #TeamCF

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

A significant commitment by CFF to help support Arcturus develop inhaled RNA therapy. Still early, but this approach to therapy would benefit people with CF no matter what their mutations - something we absolutely need! #TeamCF globenewswire.com/news-release/2…

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

30 years ago this month CFF-funded researchers discovered the CFTR gene, making possible the amazing breakthroughs that will lead in the near future to effective therapy for over 90% of people with CF. #TeamCF cff.org/Get-Involved/A…

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

#MyCFHope (and goal) is that continued aggressive research will lead to effective therapy for EACH AND EVERY PERSON WITH CF! 100% #TeamCF

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

Happy 2020! Hoping everyone had a restful and re-energizing holiday break and is now ready to charge into the next steps toward curing CF!

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

Excited about all that has been accomplished in CF but now laser focused on what lies ahead! cff.org/fiveyearplan. #cffstrategicplan

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

‘Tis the CFF chapter annual meeting season! Have had wonderful evenings with the NYC and MD CFF teams/community already, and headed to Boston this week for Mass/RI chapter meeting on Wed night. Nothing better than being together with the CF community! facebook.com/events/4347402…

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

We have been continually monitoring COVID-19 developments and CDC guidelines, plus consulting with CF infectious disease experts to provide up to date information for those with CF. cff.org/Life-With-CF/D…. Stay cautious. Stay safe.

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

While addressing COVID-19 we will also continue to work on the many other challenges that people with CF face. cff.org/News/News-Arch…

Michael Boyle (@mpboylemd) 's Twitter Profile Photo

Must reading on a path to national recovery from two former FDA commissioners and Johns Hopkins Pandemic Experts: National coronavirus response: A road map to reopening aei.org/research-produ… via American Enterprise Institute